Why is "Atomoxetine" trending?
Latest news, Wikipedia summary, and trend analysis.
Trend Analysis
- Ranking position: #
- Date: 2026-04-27 11:06:45
This topic has appeared in the trending rankings 1 time(s) in the past year. While it does not trend frequently, its appearance suggests a renewed or concentrated surge of public interest.
Based on Wikipedia pageviews and search interest, this topic gained significant attention on the selected date.
Trend Insight
Atomoxetine entered the ranking for the first time today at position #. This is its highest position ever recorded.
Trend History
This topic has appeared in the English Wikipedia rankings 1 time. It first appeared on 2026-04-27 and was most recently seen on 2026-04-27.
Wikipedia Overview
Atomoxetine, sold under the brand name Strattera, is a selective norepinephrine reuptake inhibitor (NRI) medication used to treat attention deficit hyperactivity disorder (ADHD) and, to a lesser extent, cognitive disengagement syndrome (CDS). It may be used alone or along with psychostimulant medication. It enhances the executive functions of self-motivation, sustained attention, inhibition, working memory, reaction time, and emotional self-regulation. Use of atomoxetine is only recommended for those who are at least six years old. It is taken orally. The effectiveness of atomoxetine is comparable to the commonly prescribed stimulant medication methylphenidate.
Read more on Wikipedia →Related Topics
Trending Topic Today
Search Interest Perspective
-
Comparative Risks of Pregnancy Complications in Women Prescribed Psychostimulants or Atomoxetine During Pregnancy Following Pre‐Pregnancy Stimulant Use - Psychiatry Online
-
How Does Strattera (Atomoxetine) Work for ADHD? - health.com
-
Prescription psychostimulants, atomoxetine and the risk of psychosis in adults with history of psychosis: a population-based cohort study | Translational Psychiatry - Nature
-
Aroxybutynin and Atomoxetine (AD109) Reduces Obstructive Sleep Apnea Burden in Phase 3 SynAIRgy - HCPLive
-
newsGP - PBAC to consider ADHD drugs’ initiation requirements - racgp.org.au
-
Once-nightly pill treats causes of airway collapse to control obstructive sleep apnea in large clinical trial - Medical Xpress
-
OSA severity decreases with oral aroxybutynin, atomoxetine combination over 26 weeks - Healio
-
Apnimed’s IPO Bags $192M for What Could Become the First Oral Sleep Apnea Drug - MedCity News
-
Obesity Hypoventilation Syndrome Treatment Improves Sleep - EMJ
-
Efficacy of atomoxetine and oxybutynin in the treatment of pediatric obstructive sleep apnea, a three case report - Frontiers
-
The Safety of Psychostimulants or Atomoxetine for Patients With Psychotic Disorders - Psychiatric Times
-
Comparative Risks of Pregnancy Complications in Women Prescribed Psychostimulants or Atomoxetine During Pregnancy Following Pre‐Pregnancy Stimulant Use - Psychiatry Online
-
In utero exposure to methylphenidate, amphetamines and atomoxetine and offspring neurodevelopmental disorders – a population-based cohort study and meta-analysis | Molecular Psychiatry - Nature
-
Medication initiation and optimisation in attention deficit hyperactivity disorder: A practical approach for general practice - racgp.org.au
-
FDA Approves First Nonstimulant Medication for ADHD Treatment | Psychiatric News - Psychiatry Online
-
Individualized atomoxetine response and tolerability in children with ADHD receiving different dosage regimens: the need for CYP2D6 genotyping and therapeutic drug monitoring to dance together | Translational Psychiatry - Nature
-
Atomoxetine produces oxidative stress and alters mitochondrial function in human neuron-like cells - Nature
-
Atomoxetine and Osmotically Released Methylphenidate for the Treatment of Attention Deficit Hyperactivity Disorder: Acute Comparison and Differential Response - Psychiatry Online
-
Avoiding Stimulants May Not Prevent Manic Switch: A Case Report With Atomoxetine - Psychiatry Online
-
Strattera (atomoxetine) - HealthCentral
-
The Science Behind Finding the Optimal ADHD Medication Dose - Psychology Today
-
The effects of methylphenidate and atomoxetine on Drosophila brain at single-cell resolution and potential drug repurposing for ADHD treatment | Molecular Psychiatry - Nature
-
Another Sleep Apnea Drug May Be on the Horizon for a Broader Population - MedPage Today
-
Oral aroxybutynin, atomoxetine combination lowers OSA severity over 51 weeks - Healio
-
The Top 4 Atomoxetine (Strattera) Interactions - GoodRx
-
Efficacy of Atomoxetine Versus Midodrine for the Treatment of Orthostatic Hypotension in Autonomic Failure - American Heart Association Journals
-
Case report: Atomoxetine improves chronic pain with comorbid post-traumatic stress disorder and attention deficit hyperactivity disorder - Frontiers
-
Long-term atomoxetine-oxybutynin combination use may be beneficial for the prevention of obstructive sleep apnea - Nature
-
UF researchers find ADHD drug does not heighten suicide risk despite FDA warning - UF Health
-
New Data Suggest Once-Daily Atomoxetine May Provide Symptom Relief for Up to 24 Hours - Eli Lilly
-
Proteomic analysis of Alzheimer’s disease cerebrospinal fluid reveals alterations associated with APOE ε4 and atomoxetine treatment - Science | AAAS
-
Study: Long-Term ADHD Stimulant & Non-Stimulant Use Improves Executive Function - ADDitude
-
Physiologically based pharmacokinetic modelling of atomoxetine with regard to CYP2D6 genotypes - Nature
-
Stimulants and Atomoxetine Reduce ADHD Symptoms - Medscape
-
Glenmark Recalls Nearly 1.5 Million Bottles of ADHD Drug Atomoxetine - MedCentral
-
Study Confirms Atomoxetine As an Effective Alternative to Stimulants - ADDitude
-
ADHD Medication Shortage in Japan Leaves Patients Scrambling - Unseen Japan
-
Atomoxetine cost 2026: Coupons and more - Medical News Today
-
Norepinephrine Transporter Blockade With Atomoxetine Induces Hypertension in Patients With Impaired Autonomic Function - American Heart Association Journals
-
Atomoxetine recalled due to nitrosamine impurity - link.springer.com
-
Safety and tolerability of atomoxetine hydrochloride in a long-term, placebo-controlled randomized withdrawal study in European and non-European adults with attention-deficit/hyperactivity disorder - SciELO España
-
Alternative strategy for stalling Alzheimer’s neurodegeneration - Emory News
-
newsGP - ADHD medication poisonings soar - racgp.org.au
-
Atomoxetine in Early Pregnancy and the Prevalence of Major Congenital Malformations: A Multinational Study - Psychiatrist.com
-
Methylphenidate, Atomoxetine Safe to Use in Pregnancy: New Study - ADDitude
-
Atomoxetine Increases Extracellular Levels of Norepinephrine and Dopamine in Prefrontal Cortex of Rat: A Potential Mechanism for Efficacy in Attention Deficit/Hyperactivity Disorder - Nature
-
Going forward with confidence in continuity of supply - Chemist+Druggist
-
Study Reveals Effect of ADHD Medications on Glaucoma Risk - Review of Optometry
-
ADHD Meds Linked to Cardiovascular Risk - Psychiatry Online
-
Only stimulants, atomoxetine reduce core ADHD symptoms in adults, meta-analysis shows - Healio
-
ADHD: First New Drug Class in Decades Gets FDA Approval - Denkstrom
-
ADHD Medications and Cardiovascular Effects: New Data - Medscape
-
Mixed Bag Phase 3 Data for ADHD Treatment Presented at ASHP Meeting - Psychiatric Times
-
Atomoxetine-Induced Vocal Tics in a Patient With Schizophrenia - Psychiatry Online
-
Atomoxetine as an Alternative Therapy for Adolescent Adhd With Comorbid Cerebral Palsy: A Case Report - Cambridge University Press & Assessment
-
Managing adult ADHD: Comprehensive study compares stimulants, atomoxetine and non-pharmacological therapies - Medical Xpress
-
Most Effective Treatments for Adult ADHD Identified - Medscape
-
Atomoxetine Plus Oxybutynin Improves Multiple Variables in Obstructive Sleep Apnea - Pulmonology Advisor
-
Treating Adults With ADHD Requires Special Considerations - Psychiatry Online
-
Stimulant, Non-Stimulant, or Both? Combination Therapy for ADHD - ADDitude
-
Maintenance of response after open-label treatment with atomoxetine hydrochloride in international European and non-European adult outpatients with attention-deficit/hyperactivity disorder: a placebo-controlled, randomised withdrawal study - SciELO España
-
FDA approval for generics of ADHD drug Strattera - Generics and Biosimilars Initiative
-
NORAPS Phase 2 Trial to Test Noradrenaline Reuptake Inhibitor Atomoxetine in PSP Apathy and Impulsivity - NeurologyLive
-
Assessing the Cardiovascular Effects of ADHD Medications - HMP Global Learning Network
-
Atomoxetine in comorbid ADHD/PTSD: A randomized, placebo controlled, pilot, and feasibility study - Wiley Online Library
-
SNRI 'Shows Promise' for Comorbid ADHD, PTSD - Medscape
-
Atomoxetine-Induced Pheochromocytoma and Paraganglioma Crisis Managed With Veno-Arterial Extracorporeal Membrane Oxygenation - Cureus
-
Iridium-catalyzed enantioselective synthesis of chiral γ-amino alcohols and intermediates of ( S )-duloxetine, ( R )-fluoxetine, and ( R )-atomoxetine - Nature
-
No stimulant? No Problem: Analyzing Black Market Sales of Atomoxetine on StreetRx - medRxiv
-
Pimavanserin plus atomoxetine well tolerated, lowers OSA severity - Healio
-
Atomoxetine, Oxybutynin Combination Shows Some Promise as a Treatment for Obstructive Sleep ApneaKey to Treating OSA - Managed Healthcare Executive
-
Atomoxetine Enhances Connectivity of Prefrontal Networks in Parkinson’s Disease - Nature
-
Unanticipated Pathological Laughter Following Atomoxetine Administration in a Child With Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder - Wiley Online Library
-
Viloxazine: A Nonstimulant Treatment Option for ADHD - Clinical Advisor
-
Atomoxetine Reverses Nicotine Withdrawal-Associated Deficits in Contextual Fear Conditioning - Nature
-
ADHD Drugs Negatively Affect Bone Density - Psychiatric Times
-
Insights From Dr Price: Extended-Release Viloxazine Compared With Atomoxetine for Attention-Deficit/Hyperactivity Disorder (ADHD) - HMP Global Learning Network
-
Predictors of the Pressor Response to the Norepinephrine Transporter Inhibitor, Atomoxetine, in Neurogenic Orthostatic Hypotension - American Heart Association Journals
-
Atomoxetine in comorbid ADHD/PTSD: A randomized, placebo controlled, pilot, and feasibility study - Wiley Online Library
-
Association between sleep pattern and pharmacological treatment in children with attention deficit disorder with hyperactivity: a systematic review. - Physician's Weekly
-
Adolescent Atomoxetine Treatment in a Rodent Model of ADHD: Effects on Cocaine Self-Administration and Dopamine Transporters in Frontostriatal Regions - Nature
-
Crystal structure of atomoxetine hydrochloride (Strattera), C17H22NOCl | Powder Diffraction - Cambridge University Press & Assessment
-
Atomoxetine reduces anxiety in children with ADHD - Contemporary Pediatrics
-
Late Breaking News From APSARD 2024 Conference - Psychiatric Times
-
Locus coeruleus integrity and the effect of atomoxetine on response inhibition in Parkinson’s disease - Oxford Academic
-
Obstructive sleep apnea combination drug safe, reduces disorder severity over 1 month - Healio
-
FDA Approves First Generic Versions of Strattera - ADDitude
-
Signal for atomoxetine-associated neutropenia in children - link.springer.com
-
Similar Effects of the Selective Noradrenaline Reuptake Inhibitor Atomoxetine on Three Distinct Forms of Impulsivity in the Rat - Nature
-
Pattern Classification of Working Memory Networks Reveals Differential Effects of Methylphenidate, Atomoxetine, and Placebo in Healthy Volunteers - Nature
-
Hyloris Announces Out-Licensing of Atomoxetine Oral Liquid in Canada - Yahoo Finance
-
Lilly Announces Important Liver Safety Update to Strattera(R) Label - Eli Lilly
-
Dr. Reddy's banned from China's drug procurement program after inspectors turn up manufacturing problems - Fierce Pharma
-
Many ADHD Medications Lead to Increases in Blood Pressure and Heart Rate - Physician's Weekly
-
FDA Drug Recalls and Warnings: Recalls for ADHD Meds and Acne Treatments, Plus More - MedShadow Foundation
-
All ADHD Meds Tied to Small Blips in Blood Pressure and Pulse - MedPage Today
-
Oxford and Southampton study identifies the most effective treatments for ADHD in adults - Oxford Health NHS Foundation Trust
-
Low-Dose ADHD Medications Not Associated With Changes in Thyroid and Growth Hormones in Children - Endocrinology Advisor
-
Glenmark issues another recall, this time for nearly 1.5M bottles of generic ADHD drug - Fierce Pharma
-
Lilly Agrees to Add Warning On Strattera Labeling - Psychiatry Online
Why This Topic Is Trending
This topic has recently gained attention due to increased public interest. Search activity and Wikipedia pageviews suggest growing global engagement.
Search Interest & Related Topics
Search interest data over the past 12 months indicates that this topic periodically attracts global attention. Sudden spikes often correlate with major news events, public statements, or geopolitical developments.